NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.
Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.
UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.
NCI, SAIC To Support Contracts For Molecular Target Labs.
NCAB: An Extraordinary Opportunity For Budgetary Coordination.
Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.
BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.
Aventis, MediGene In Pact For Development Of Vaccine.
Firm To Study Imaging System As Adjunct To Mammogram.
Techniclone Wins Patent For Tumor Necrosis Therapy.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
